See How RestoreX Compares
RestoreX – the only second-generation penile traction device.
Comparison of RestoreX to first-generation traction systems
| Device | RestoreX | AndroPenis | X4 | PeniMaster |
|---|---|---|---|---|
| Treatment time/week | 30 min, 1-2x/day | 9 or more hours/day | 5 or more hours/day | 3 or more hours/day |
| Physician invented (Peyronie’s and ED specialist) |  |  | | |
| Opposite force angulation for traction directed at disease site | | | | |
| Optimized treatment zone for continuous traction | | | | |
| Randomized clinical trial data for 30 minutes of treatment per day | | | | |
| Randomized clinical trial data for lengthening after surgery or chronic disease | | | | |
| Largest number of scientific publications demonstrating efficacy | | | | |
| Recommended most by sexual medicine specialists * | | | | |
Sources: Company websites and Instructions for Use manuals. Last updated on September 12, 2024.
* Source: SMSNA Members 2024 Annual Survey
RestoreX is the
Most Preferred Traction Device
Watch this video to understand why RestoreX is considered the only “Next Generation Penile Traction Therapy Device”
RestoreX was recommended by more sexual medicine specialists than any other device
After three weeks of use, nearly 74% of men in the trial who used traction indicated that traction with RestoreX would be their preferred therapy to treat PD if they were starting treatment for the first time over different interventions such as surgery, oral medication, other traction devices, vacuum erection devices or Xiaflex. (Please note men could indicate more than one treatment.)
Notably, all men who had used another traction device prior to starting the clinical trial stated that RestoreX was either much better (87%) or somewhat better (13%) than the other traction device(s) they had previously used.
Source: Restorex® for PD, 3 Month Data
What makes Restorex different
Greater Force Achieved
RestoreX is able to achieve greater traction forces than other devices. This is likely one reason why shorter treatment times are required and why results show more consistent benefits.
Unique Clamping Mechanism
RestoreX clamps the full head of the penis. This is significantly more comfortable than mechanisms employed by other devices which employ suction cups or rubber rings around the head of the penis.
Counterbending
RestoreX is the only traction device with a built-in counterbending mechanism. The counterbending mechanism can be adjusted to target specific regions of the penis affected by Peyronie’s disease.
Dynamic Adjustment
RestoreX can be adjusted while being worn to deliver optimal treatment in a short time.
Indicator Line
RestoreX provides user feedback via a white indicator line on the rods so patients are assured they receive ideal traction force and treatment.
Unique Clamping Mechanism
Counterbending
RestoreX is the only traction device with a patented counterbending mechanism. The counterbending mechanism can be adjusted to target specific regions of the penis affected by Peyronie’s disease.
Dynamic Adjustment
RestoreX can be adjusted while being worn to deliver optimal treatment in a short time.
Indicator Line
RestoreX provides user feedback via a white indicator line on the rods so patients are assured they receive ideal traction force and treatment.
Greater Force
Because of the above design features, RestoreX is able to provide greater traction forces than other devices, resulting in shorter treatment times. RestoreX achieves consistent results in 30 minutes while other devices require 2-9 hours daily.
Short Treatment Time
RestoreX achieves results in as little as 30 minutes daily while other devices require 2-9 hours every day.
in curvature
other traction devices
RestoreX by PathRight Medical was developed in cooperation with, and exclusively licensed from, Mayo Clinic. Review Proven Clinical Results to learn more about the results you can expect using RestoreX for 30 to 60 minutes per day.
We have the science to prove it:
RestoreX is the only traction therapy device studied in a randomized, controlled clinical trial in the USA in men with chronic Peyronie’s disease. The 3-month results from the study of men with PD were published in the Journal of Urology in September 2019 and the 6-month results published in the Journal of Sexual Medicine in December 2020. Additionally, numerous additional prospective studies have been conducted using the device in different situations, including as a combination therapy with Xiaflex injections.
RestoreX is also the only device to conduct a clinical trial in the US for lengthening and erectile function preservation/improvement in men post-prostatectomy or men with a chronic disease such as Diabetes. Results of these studies have been presented at national scientific meetings and are published in the Journal of Urology (2021) and in the British Journal of Urology International (2023).
In the only head-to-head study performed of Restorex with other traction devices, only Restorex was shown to increase penile length and further improve outcomes of Xiaflex injections. See the clinical results section clinical results section for more details on each of these studies.